Fulcrum Pharma Overview
- Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
Merger of Eq.
- Financing Rounds
-
4
- Investments
-
1
Fulcrum Pharma General Information
Description
Provider of drug development support services intended to deliver products faster and more efficiently to the global pharmaceutical market. The company's drug development support services offers assistance to companies in various stages of drug development from research through approval and post-marketing, enabling pharmaceutical and biotechnology companies to achieve drug development and regulatory approval milestones.
Contact Information
Website
www.fulcrumpharma.com
Formerly Known As
Protodigm
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Consulting Services (B2B)
Other Industries
Drug Discovery
Acquirer
Former Stock Listing
FUL
Primary Office
- Hemel One Boundary Way
- Hemel Hempstead HP1 1JY
- England, United Kingdom
Fulcrum Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Fulcrum Pharma Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jon Court | Chief Executive Officer |
Fulcrum Pharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Fulcrum Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Fulcrum Pharma Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000 | 19-Mar-2007 | 0000000000 | 00.000 | Consulting Services (B2B) | 000 00000 |